Skip to main content
. 2023 Jun 20;12(12):4160. doi: 10.3390/jcm12124160

Table 2.

Evaluation of laboratory tests among the investigated groups.

Parameter Patients with Symptoms
n = 44
Patients without Symptoms
n = 102
p
Laboratory tests
hs-cTnT (pg/mL) (3.20–9.00), 6.10 * (3.00–6.20), 3.90 * 0.04
NT-proBNP (pg/mL) (42.00–125.00), 86.00 * (29.00–123.00), 61.00 * 0.051
RBC (106/uL) (4.13–4.80), 4.42 * (4.32–5.08), 4.62 * 0.01
Hemoglobin (g/dL) (12.60–14.50), 13.30 * (13.00–15.30), 13.90 * 0.07
PLT (103/uL) 218.87 (±54.59) 223.11 (±54.56) 0.67
Creatinine (mg/dL) (0.67–0.89), 0.79 * (0.66–0.90), 0.77 * 0.87
GFR (mL/min/1.73 m2) (76.10–98.80), 88.25 * (81.80–111.30), 94.90 * 0.03
Urea (mg/dL) 35.24 (±11.26) 31.75 (±9.36) 0.07
Glucose (mg/dL) (86.00–99.00), 91.50 * (84.50–93.00), 90.00 * 0.03
ALT (U/L) (18.00–29.00), 22.50 * (14.50–34.00), 23.00 * 0.93
ASP (U/L) (24.00–30.00), 26.50 * (23.50–38.00), 27 * 0.37
CRP (mg/dL) (0.50–0.50), 0.50 * (0.50–0.50), 0.50 * 0.82
D-dimer (ng/mL) (186.00–450.00), 279.00 * (197.00–439.00), 276.00 * 0.82
TC (mg/dL) 171.32 (±40.71) 173.55 (±45.88) 0.77
LDL (mg/dL) 94.54 (±34.86) 96.80 (±29.01) 0.71
HDL (mg/dL) (40.00–58.00), 49.50 * (36.00–59.50), 50.50 * 0.99
TG (mg/dL) (86.00–163.00), 111.50 * (80.00–150.00), 101.00 * 0.57
Na (mmol/L) (138.00–140.00), 139.00 * (137.50–140.00), 139.00 * 0.20
K (mmol/L) (4.20–4.60), 4.30 * (4.10–4.55), 4.30 * 0.74

*—median; values with a non-normal distribution are expressed as median (range) values. Values with normal distributions are expressed as the mean ± standard deviation (SD). hs-cTnT—high-sensitivity cardiac troponin; NT-proBNP—N-terminal prohormone of brain natriuretic peptide; RBC—red blood cells; PLT—thrombocytes; GFR—glomerular filtration rate; ALT—alanine aminotransferase; AST—aspartate aminotransferase; CRP—c-reactive protein; TC—total cholesterol; LDL—low-density lipoprotein; HDL—high-density lipoprotein; TG—triglycerides; Na—serum natrium; K—serum potassium.